443-41-4

Usage

Uses

Used in Pharmaceutical Industry:
2,6-Dibromo-4-fluoroanisole is used as a building block for the synthesis of various pharmaceuticals, contributing to the development of new drugs and improving existing ones. Its unique chemical structure allows for the creation of diverse compounds with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical industry, 2,6-Dibromo-4-fluoroanisole serves as a key intermediate in the production of various agrochemicals, such as pesticides and herbicides. Its incorporation into these products helps enhance their effectiveness in controlling pests and weeds, thereby improving crop yields and quality.
Used in Organic Compounds Production:
2,6-Dibromo-4-fluoroanisole is utilized as an intermediate in the synthesis of other organic compounds, expanding its applications across various chemical industries. Its versatility in chemical reactions enables the production of a wide range of compounds with different properties and uses.

InChI:InChI=1/C7H5Br2FO/c1-11-7-5(8)2-4(10)3-6(7)9/h2-3H,1H3

Upstream product

• 344-20-7 2,6-dibromo-4-fluorophenol 
• 77-78-1 dimethyl sulfate 
• 371-41-5 4-Fluorophenol 

Downstream Products

• 19643-45-9 2,6-dibromo-1,4-benzoquinone 
• 346664-78-6 1,3-dibromo-5-fluoro-2-methoxy-4-nitro-benzene 
• 1265218-50-5 2-(7-fluoro-4-methoxy-1-methyl-5-phenyl-1H-indol-3-yl)-N,N-dimethylacetamide 
• 1265218-38-9 2,4-dibromo-6-fluoro-3-methoxyaniline 
• 1265218-40-3 N-(2,4-dibromo-6-fluoro-3-methoxyphenyl)acetamide 
• 1051899-78-5 2-chloro-N-(2-fluoro-5-methoxyphenyl)pyrimidin-4-amine 
• 62257-15-2 2-fluoro-5-methoxyaniline 
• 1182728-33-1 1-benzylsulfanyl-3-bromo-5-fluoro-2-methoxy-benzene 

Relevant academic research and scientific papers

COMPOUNDS AND METHODS OF USE THEREOF

Indole compounds are disclosed. Also disclosed are methods for using the compounds to treat human and animal disease, pharmaceutical compositions of the compounds, and kits including the compounds.

NOVEL PYRIMIDINE DERIVATIVES 698

The invention concerns compounds of Formula (I), or a pharmaceutically acceptable salt thereof, where R1, n, R2, R3, and R4 are as defined in the description. The present invention also relates to processes for the preparation of such compounds, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use as an antiproliferative agent in the prevention or treatment of tumours or other proliferative conditions which are sensitive to the inhibition of EphB4 kinases.

Novel compounds

Compounds of general formula (I), R1 is selected from any one of phenyl, pyridinyl, thiophenyl, furanyl, imidazolyl, and triazolyl; where each R1 phenyl ring and R1 heteroaromatic ring may optionally and independently be further substituted by 1, 2 or 3 substituents selected from straight and branched C1-C6 alkyl, NO2, CF3, C1-C6 alkoxy, chloro, fluoro, bromo, and iodo. The substitutions on the phenyl ring and on the heteroaromatic ring may take place in any position on said ring systems; Ra and Rb is each and individually selected from any one of hydrogen, a straight and branched C1-C6 alkyl, NO2, CF3, C1-C6 alkoxy, chloro, fluoro, bromo, and iodo; are disclosed and claimed in the present application, as well as their pharmaceutically acceptable salts and pharmaceutical compositions comprising the novel compounds and their use in therapy, in particular in the management of pain.